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Methods: Regional mean standardized uptake value ratios were extracted from [18F]flortaucipir
positron emission tomography (PET) scans of 82 at-risk adults in the Alzheimer’s Disease Neuroi-
maging Initiative (ADNI) cohort. Associations between self– and informant ECog memory scores
and tau aggregation were analyzed on both regional and voxelwise bases. Analyses were completed
both on the whole sample and restricted to amyloid-positive individuals only.
Results: Memory concerns were associated with tau aggregation. Self-perception was more associ-
ated with frontal tau. In contrast, informant scores were more associated with parietal tau. This
source-by-region interaction was more prominent in amyloid-positive participants and observed in
both regional and voxelwise analyses.
Discussion: Quantitative assessment of perceived memory functioning may be useful for screening
older adults at risk for Alzheimer’s disease. Individuals and their informants may provide comple-
mentary information relating to the anatomical distribution of tau.
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Alzheimer’s disease (AD), the leading cause of neurode-
generative dementia associated with aging, affects over 5
million adults in the United States and is predicted to in-
crease to 16million affected by 2050 [1]. There are presently
no approved pharmacological treatments that can stop the
progression of AD. Treatment is likely to be most effective
during the preclinical or early prodromal stages of AD,
before substantial permanent neurodegenerative and cogni-
tive damage has occurred. Therefore, there has been consid-
erable recent interest in measures to identify older adults at
highest risk for progression to AD who may benefit most
from early intervention [2,3].eimer’s Association. This is an open access article under the CC BY license
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presence of normal neuropsychological test scores are at
an increased risk of progression to AD. These adults
have been shown to progress to mild cognitive impairment
(MCI) and eventually AD or a related dementia at a higher
rate than cognitively normal (CN) adults who do not have
SCD [2,4–8]. Adults with SCD also show subtle,
subclinical differences in objective cognitive performance
compared to adults without SCD and experience more
functional decline over time [9]. Therefore, it has been
suggested that SCD is potentially a preclinical stage of
AD [9]. However, SCD has also been linked to depression,
other affective disorders, and personality traits [7,10–13].
Therefore, it is necessary to determine the factors that
influence the clinical and prognostic significance of SCD.
In addition to capturing self-based estimates of SCD, in-
vestigators often also assess the extent of concerns about
cognitive decline from an informant (spouse, child, other
caregiver, or clinician). Informant-based cognitive concerns
are particularly important in the later stages of cognitive
decline, when individuals’ insight into their own cognitive
problems diminishes and informant perceptions of cognition
are more accurate [12,14,15]. In CN adults, however, self-
and informant perceptions of cognitive decline are both
predictive of future progression to MCI or AD, and the use
of both measures together is a better predictor than either
measure alone [5]. This finding suggests that, in very early
stages of disease, both at-risk adults and their informants
can provide important information about subclinical cogni-
tive decline. Thus, using both sources of concern together
may provide complementary information regarding subtle
pathological changes in adults in very early preclinical
stages of AD.
Many adults with SCD exhibit structural and pathological
changes that are typically associated with MCI or AD. For
example, adults with SCD show patterns of neurodegenera-
tion, such as decreased gray matter and hippocampal vol-
umes, that are similar to those seen in adults with MCI
[16–18]. Similarly, some adults with SCD and early mild
cognitive impairment (EMCI) show AD-related pathology,
such as amyloid plaques, tau tangles, and cerebrospinal fluid
(CSF) profiles that are similar to those observed in AD
(decreased levels of amyloid and increased levels of total
and phosphorylated tau; [19–21]). Adults with SCD or
EMCI who also show AD-like pathology are more likely
to progress to later stages of MCI or AD [21,22].
Tau aggregation is an important biomarker of disease
severity along the spectrum of preclinical and clinical stages
of AD. It has been previously established from measure-
ments of tau in CSF and postmortem studies of brain tissue
that tau aggregation correlates with both neurodegeneration
and the resultant cognitive decline temporally and spatially
during progression of AD [23,24]. The recent development
of tau-specific radiotracers has allowed in vivo positron
emission tomography (PET) measurement and visualization
of the spatial distribution of tau aggregation for the first time[25]. Tau radiotracers have permitted in vivo correlation of
tau aggregation and other markers of disease progression,
including increased cognitive decline, amyloid deposition,
and CSF measures of amyloid and tau [26]. Spatial informa-
tion about the tau anatomical distribution has also been
shown to provide important clinical information; brain re-
gions with high levels of tau aggregation often correspond
to declines in cognitive functions related to those regions
[27].
Because tau aggregation correlates spatially with brain
areas implicated in cognitive decline, it is possible that
self-based memory concerns correlate more strongly with
tau aggregation in brain regions involved in introspection
or internal thought processes, for example, the medial pre-
frontal cortex. More generally, the frontal cortex has been
implicated in several aspects of conscious internal process-
ing, such as planning, decision-making, and inhibition of ac-
tions by thinking through consequences. It is possible that
preclinical pathological changes in frontal brain regions
would be noticeable to the patient before causing outward
changes in behavior due to impacts on the processes of inter-
nal thought. On the other hand, informant memory concerns
may correlate more strongly with tau aggregation in brain re-
gions typically seen in patients with MCI and AD, as these
may be involved in common initial symptoms of AD (i.e.,
memory decline) that are more likely to be noticed by an
observer.
To determine how self- and informant perceptions of
cognitive decline are each related to tau deposition in the
early stages of AD, we assessed the relationship between
self- and informant scores on the memory subscale of the
Test of Everyday Cognition (ECog; [28]), as well as the as-
sociation of each with regional and global tau aggregation as
measured by the tau PET radiotracer [18F]flortaucipir
(T-807; AV-1451). Our goal was to evaluate the relationship
between self– and informant memory concerns and tau
deposition to investigate the biological basis for the predic-
tive power of cognitive concerns and whether the self- and
informant concerns could be utilized as part of a screening
protocol to assess preclinical AD in individual adults. We
included older adults enrolled in the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) who were defined as CN
controls, had significant memory concerns (SMCs), or had
EMCI. These adults comprise a continuum of risk for devel-
oping clinical AD. A subset of the CN older adults are
amyloid negative and apolipoprotein E gene (APOE) ε4 non-
carriers and thus are at risk for AD due to age alone and are
on the “low-risk” end of the continuum. On the “high-risk”
end are adults with EMCI who have subtle cognitive decline,
presence of self– and informant cognitive concerns, and are
amyloid positive and/or APOE ε4 carriers. We examined the
association of self– and informant ECog memory scores
with one another and with tau aggregation in all participants.
Following these analyses, we completed a subanalysis using
only participants who are amyloid positive because these
participants are at a relatively higher risk of developing
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ory scores would be mildly correlated with one another, and
that higher ECog memory scores (indicating greater
perceived memory decline) would be associated with
increased levels of tau. Finally, we also hypothesized that
self- and informant scores would potentially correlate with
the distribution of tau aggregation in spatially different pat-
terns of association throughout the brain.2. Methods
2.1. Participants
Data used in the preparation of this article were obtained
from the ADNI database (http://adni.loni.usc.edu;
Supplementary Material). For up-to-date information, see
http://www.adni-info.org. The 82 participants included in
this study were diagnosed as CN older adults, SMC partici-
pants, or EMCI participants by the ADNI-2 procedures
manual criteria (http://www.adni-info.org). According to
these criteria, 40 CN participants had no subjective or infor-
mant complaint of cognitive decline and performed nor-
mally on the Wechsler Logical Memory Delayed Recall
(LM-delayed) and the Mini–Mental State Examination
(MMSE). 11 SMC participants expressed subjective mem-
ory concerns on the Cognitive Change Index (CCI; total
score from first 12 items  16 [29,30]) but had no
significant informant complaint of cognitive decline and
performed normally on the LM-delayed andMMSE. Finally,
31 EMCI participants had subjective, informant, and/or
clinician complaint of cognitive decline, memory function
approximately one standard deviation (SD) below normal
on the LM-delayed, a MMSE total score greater than 24,
and functioning at a level that precluded a diagnosis of
AD. For the amyloid-positive group, we included only CN,
SMC, and EMCI participants who were amyloid positive
(n 5 36; 15 CN, 4 SMC, and 17 EMCI) on the [18F]florbe-
tapir PET scan closest to the [18F]flortaucipir PET scan, us-
ing data generated by the University of California, Berkeley,
and downloaded from the ADNI site (global standardized
uptake value ratio [SUVR] . 1.11 [31]). The percentage
of subjects that were amyloid positive did not differ by the
diagnostic group.
2.2. Clinical and cognitive assessments
Clinical and cognitive performance data were obtained
from the ADNI database (http://adni.loni.usc.edu). Partici-
pants were given clinical and cognitive tests as described
in the ADNI-2 manual (www.adni-info.org). For the primary
analyses, we used self– and informant ECog memory scores,
which are the averages of ratings on the eight questions in
the memory section of the ECog. The ECog score from the
test given closest in time to the [18F]flortaucipir scan was
used [full sample: mean (SD) 5 145.5 (186.8) days;
amyloid-positive sample: mean (SD) 5 128.4 (158.2)
days], which did not differ by the diagnostic group.2.3. [18F]flortaucipir PET scans
Preprocessed [18F]flortaucipir PET scanswere downloaded
from the ADNI Laboratory of Neuro Imaging (LONI; http://
adni.loni.usc.edu) site. These scans were preprocessed using
standard techniques in Statistical Parametric Mapping 8
(SPM8), including normalization to Montreal Neurologic
Institute (MNI) space. Then, SUVR images were created
by intensity normalization using a cerebellar crus reference
region. Regional mean SUVR was extracted from subject-
specific regions of interest (ROIs), including the bilateral
mean parahippocamapal gyri, frontal lobe, parietal lobe, and
global cortex. ROIs were generated from the closest in
time structural MRI scan using FreeSurfer, version 5.1.
2.4. Statistical analysis
Partial Pearson correlationswere used to assess the associ-
ation between self– and informant ECog memory scores and
with tau aggregation in the target ROIs using SPSS Statistics,
version 24 (IBM Corporation, Somers, NY). Covariates for
these analyses included age, sex, and years of education.
Furthermore, APOE ε4 carrier status (where positive is hav-
ing at least one APOE ε4 allele and negative is not having
an APOE ε4 allele regardless of whether the other alleles
are APOE ε2 or APOE ε3) and Geriatric Depression Scale
(GDS) total score were tested as potential covariates in sec-
ondary analyses. The associations were assessed in thewhole
group of participants, as well as in amyloid-positive partici-
pants only and in amyloid-negative participants only.
c2 testswere used to evaluate the association of sex,APOE
ε4 positivity, or amyloid positivity with the diagnostic group.
A one-way analysis of variance (ANOVA) was used to assess
differences in age, years of education, a composite memory
score, GDS score, self–ECog memory score, and informant
ECog memory score by the diagnostic group. Again, these
associations were examined using all participants and in
amyloid-positive participants only. Post hoc differences
were evaluated after Bonferroni adjustment formultiple com-
parisons, withP, .05 after correction considered significant.
2.5. Voxelwise analysis
In addition, the associations of self– and informant ECog
memory scores and [18F]flortaucipir SUVR were evaluated
on a whole-brain voxelwise basis in SPM8 using a multiple
linear regression model, masked for the gray plus white mat-
ter, and including age, sex, and years of education as covari-
ates. Significance was set at a voxelwise threshold of
P, .005 (uncorrected for multiple comparisons) and a min-
imum cluster size (k) of 675 voxels, which corresponds to a
clusterwise threshold of P , .05 (familywise error [FWE]
correction for multiple comparisons). Talairach Daemon
was used to identify brain regions of significant clusters.
As in the regional analyses, the voxelwise analyses included
an initial analysis using the whole sample and a follow-up
analysis included amyloid-positive participants only.
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3.1. Demographics
Effects of diagnosis on demographics, neuropsychologi-
cal test scores, and self– and informant ECog memory scores
are shown in Table 1 for all participants and in
Supplementary Table 1 for amyloid-positive participants.
For all participants, as expected, participants with EMCI
had lower memory performance with lower composite
scores than CN participants (P 5 .007). Participants with
EMCI had higher informant ECog memory scores than CN
participants (P , .001). Sex was significantly different
across diagnostic groups such that men made up a greater
percentage of the EMCI group, whereas women made up a
greater percentage of the CN group (P 5 .049). There
were no significant differences in age, years of education,
GDS scores, APOE ε4 positivity, amyloid positivity, or
self–ECog memory scores between diagnostic groups. For
amyloid-positive participants, participants with EMCI had
lower memory composite scores than CN participants
(P 5 .045). Participants with EMCI also had higher infor-
mant ECog memory scores than CN participants
(P5 .019). No significant differences in age, years of educa-
tion, sex, GDS scores, APOE ε4 genotype, or self–ECog
memory scores were observed between diagnostic groups.
3.2. Association of self– and informant ECog memory
scores
Self–ECog memory scores were only mildly correlated
with informant ECog memory scores, after covariate adjust-
ment, when all participants were included (r 5 0.362,
rp 5 0.001). When only amyloid-positive participants were
included, the correlation between self– and informant
ECog memory scores did not reach statistical significance
(r 5 0.243, rp 5 0.173).
3.3. Regional analysis in all participants
Self–ECog memory scores were significantly correlated
with tau aggregation, after covariate adjustment, in all fourTable 1
Demographic information for all participants
Variable CN (n 5 40) SMC (n 5 11)
Age (y) 76.48 (7.211) 71.55 (5.11)
Education (y) 16.03 (2.37) 16.00 (2.49)
Sex (M, F) 17, 23 5, 6
APOE ε4 positivity (%) 42.5 45.5
Amyloid positivity (%) 37.5 36.4
Memory composite 1.23 (0.67) 1.20 (0.63)
GDS total 1.21 (1.59) 0.91 (0.83)
Self–ECog memory 1.77 (0.66) 1.88 (0.68)
Informant ECog memory 1.41 (0.48) 1.52 (0.50)
Abbreviations: APOE, apolipoprotein E; CN, cognitively normal; ECog, Test
F, female; GDS, Geriatric Depression Scale; SMC, significant memory concern.
*P , .05 (Bonferroni adjustment for multiple comparisons).ROIs (parahippocampal: rp 5 0.293, P 5 .009; frontal:
rp 5 0.329, P 5 .003; parietal: rp 5 0.291, P 5 .009; and
global: rp 5 0.306, P 5 .006; Fig. 1A). Informant ECog
memory scores were similarly significantly associated with
tau aggregation in all four regions, but the correlation with
tau aggregation in the parietal regionwas the strongest (para-
hippocampal: rp 5 0.283, P 5 .011; frontal: rp 5 0.259,
P 5 .021; parietal: rp 5 0.411, P , .001; and global:
rp 5 0.296, P 5 .008; Fig. 1B).3.4. Regional analysis in amyloid-positive participants
When only amyloid-positive participants were included,
self–ECog memory scores were again significantly corre-
lated with tau aggregation in all four regions, and the stron-
gest association was in the frontal lobe (parahippocampal:
rp5 0.411, P5 .018; frontal: rp5 0.517, P5 .002; parietal:
rp 5 0.352, P 5 .044; and global: rp 5 0.459, P 5 .007;
Fig. 2A). Alternatively, informant ECog memory scores
were significantly correlated with tau aggregation in all re-
gions except for the frontal region (parahippocampal:
rp5 0.347, P5 .048; frontal: rp5 0.341, P5 .052; parietal:
rp5 0.514, P5 .002; and global: rp5 0.416, P5 .016), and
the strongest correlation with tau aggregation was in the pa-
rietal region (Fig. 2B). When only amyloid-negative partic-
ipants were included, neither self– nor informant ECog
memory scores were correlated with tau aggregation in
any of the ROIs (data not shown).3.5. Interaction analysis
To determine whether there is a significant interaction of
source of cognitive concern (self vs. informant) and location
of tau deposition (frontal vs. parietal), we calculated the dif-
ference scores by subtracting informant ECog memory
scores from self-ECog memory scores and mean frontal
parietal from mean frontal [18F]flortaucipir SUVR. We
then evaluated the association between these two difference
scores. A statistically significant concern source-by-region
interaction was observed in which self-scores are preferen-
tially associated with tau aggregation in frontal regionsEMCI (n 5 31) P value Significant pair comparisons*
75.32 (7.29) .125 None
17.03 (2.39) .184 None
22, 9 .049 N/A
25.8 .256 N/A
54.8 .297 N/A
0.73 (0.69) .007 EMCI , CN
1.52 (1.88) .527 None
2.11 (0.68) .114 None
2.02 (0.77) ,.001 EMCI . CN
of Everyday Cognition; EMCI, early mild cognitive impairment; M, male;
Fig. 1. Association of self– and informant memory concerns with tau. Self–ECogmemory scores associate more strongly with (A) tau aggregation in the frontal
lobe (rp5 0.329, P5 .003) than (B) that in the parietal lobe (rp5 0.291, P5 .009). Alternatively, informant ECog memory scores associate more strongly with
tau aggregation (D) in the parietal lobe (rp5 0.411, P, .001) than (C) that in the frontal lobe (rp5 0.259, P5 .021). However, all associations are significant
(P , .05). Scatterplots show raw data points; rp values and P values were generated from a model with age, sex, and years of education as covariates. Abbre-
viations: CN, cognitively normal; ECog, Test of Everyday Cognition; EMCI, early mild cognitive impairment; SUVR, standardized uptake value ratio.
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aggregation in parietal regions, both in all participants and
in amyloid-positive participants (Fig. 3).
Including either APOE ε4 allele positivity or GDS scores
as additional covariates did not change the observed pattern
of results in either the full sample or the amyloid-positive
only sample (data not shown).3.6. Voxelwise analyses
To assess the spatial differences between the associa-
tions with tau and self- and informant ECog memory
scores without the bias of using our predetermined ROIs,
we performed voxelwise analyses in SPM8. In all partici-
pants, the self–ECog memory scores were associated
with tau in the following regions: bilateral frontal lobe
(middle, medial, superior, and inferior frontal gyri), left
frontal subgyral region, right temporal lobe (middle, supe-
rior, inferior, and fusiform gyri and subgyral region), bilat-
eral precentral gyrus, left postcentral gyrus, bilateral
cingulate gyrus, bilateral anterior cingulate, bilateral poste-
rior cingulate, right parahippocampal gyrus, right precu-neus, right insula, right uncus, and anterior lobe of right
cerebellum (clusterwise threshold of P , .05 FWE;
Supplementary Table 2; Fig. 4A). Informant ECog memory
scores were associated with tau aggregation in the
following regions: bilateral frontal lobe (middle, medial,
and superior frontal gyri), right frontal subgyral region,
bilateral temporal lobe (middle, inferior, and fusiform
gyri), left superior temporal gyrus, right supramarginal gy-
rus, bilateral precentral gyrus, right inferior parietal lobule,
right occipital lobe (middle and superior occipital gyri),
left inferior occipital gyrus, bilateral precuneus, left cu-
neus, bilateral posterior cingulate, bilateral cingulate gyrus,
right insula, bilateral posterior lobe of cerebellum, and
anterior lobe of left cerebellum (clusterwise threshold of
P , .05 FWE; Supplementary Table 3; Fig. 4B).
In amyloid-positive participants, self–ECog memory
scores were associated with tau aggregation in the following
regions: bilateral frontal lobe (middle, inferior, and subcal-
losal gyri), left medial frontal gyrus, right temporal lobe
(middle and inferior temporal gyri), right precentral gyrus,
bilateral anterior cingulate, right putamen, right uncus, right
insula, and anterior lobe of right cerebellum (clusterwise
Fig. 2. Association of self– and informant memory concerns with tau in amyloid-positive participants. Similar to the pattern observed in all participants, self–
ECog memory scores associate more strongly with (A) tau aggregation in the frontal lobe (rp5 0.517, P5 .002) than (B) that in the parietal lobe (rp5 0.352,
P5 .044). Contrary to this, informant ECog memory scores associate strongly with tau aggregation (D) in the parietal lobe (rp5 0.514, P5 .002) and (C) are
borderline significantly associated with tau aggregation in the frontal lobe (rp5 0.341, P5 .052). Scatterplots show raw data points; rp values and P values were
generated from a model with age, sex, and years of education as covariates. Abbreviations: CN, cognitively normal; ECog, Test of Everyday Cognition; EMCI,
early mild cognitive impairment; SUVR, standardized uptake value ratio.
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Informant ECogmemory scores were associated with tau ag-
gregation in the following regions: bilateral frontal lobe
(middle, medial, superior, and inferior gyri and subgyralFig. 3. Source-by-region interaction analysis. Self– and informant ECogmemory s
regions, respectively. The source-by-region interactions (A) for all participants (r
P 5 .006) are statistically significant. Graphs plot rp values from partial Pearson
age, sex, and years of education as covariates. Statistical significance of the sou
between the source difference score (self-score minus informant score) and the
were age, sex, and years of education. Abbreviations: SUVR, standardized uptakeregion), bilateral middle temporal gyrus, right supramargi-
nal gyrus, left superior temporal gyrus, bilateral precentral
gyrus, right postcentral gyrus, bilateral precuneus, bilateral
cingulate gyrus, bilateral posterior cingulate, left cuneus,cores are most strongly associated with tau aggregation in frontal and parietal
p 5 0.283, P 5 .012) and (B) for amyloid positive participants (rp 5 0.47,
correlations between each ECog memory score and region of interest with
rce-by-region interactions was determined by a partial Pearson correlation
region difference score (frontal SUVR minus parietal SUVR). Covariates
value ratio; ECog, Test of Everyday Cognition.
Fig. 4. Voxelwise association between self– and informant memory concerns and tau aggregation. (A) Voxelwise analysis of [18F]flortaucipir PET scans shows
statistically significant clusters of association between self–ECog memory scores and tau aggregation across all participants, in primarily bilateral frontal and
right temporal lobe regions. (B) Informant ECog memory scores were associated with tau deposition on [18F]flortaucipir PET in bilateral frontal, bilateral pa-
rietal, bilateral temporal, and bilateral occipital lobes, as well as the bilateral cerebellum across all participants. In amyloid-positive participants only, voxelwise
analysis showed statistically significant clusters of association between (C) self–ECog memory scores and tau aggregation correlation in bilateral frontal lobes,
right temporal lobe, and right cerebellum and between (D) informant ECogmemory scores and tau aggregation correlation in the left parietal, bilateral occipital,
and bilateral frontal lobes. The figures are displayed at a voxelwise threshold of P , .005 (uncorrected for multiple comparisons); minimum cluster size
(k) 5 675 voxels. Abbreviations: PET, positron emission tomography; ECog, Test of Everyday Cognition.
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wise threshold of P , .05 FWE; Supplementary Table 5;
Fig. 4D).4. Discussion
In this study, we found that self– and informant memory
concerns are both correlated with tau aggregation in at-risk
adults, but that the overall spatial patterns of associations
differ between the two measures of subjective memory
concern. We found that self– and informant ECog memory
scores are only mildly correlated with one another in at-
risk adults and are not correlated with one another in the sub-
set of amyloid-positive adults, suggesting that the two mea-
sures of subjective memory complaints may be somewhat
independent and provide complementary information. The
results from our ROI-based analyses suggest that self-
based memory complaints are most strongly associated
with tau aggregation in the frontal lobes, whereas informant
memory complaints are most strongly associated with tau
aggregation in the parietal lobes. These differences in pat-terns of correlation were enhanced when only amyloid-
positive participants were included, and significant source-
by-region interactions were found in both the full analysis
and the subanalysis of amyloid-positive individuals. There
were no correlations found when only amyloid-negative par-
ticipants were included, suggesting that the patterns of asso-
ciation found are specifically present in adults at higher risk
for developing AD, which supports the idea that these sub-
jective memory tools may be useful for optimizing screening
techniques in the population of at-risk adults. In addition to
our regional analyses, we evaluated the associations with
voxelwise analyses to lessen the bias imposed by our prede-
termined ROIs. Although these analyses revealed regions of
overlap between the correlations of tau aggregation with
self– and informant memory concerns, they resulted in the
same general patterns found with the ROI-based analyses.
Specifically, both self– and informant memory concerns
were associated with tau aggregation in the frontal and tem-
poral lobes when all participants were included, while the
informant memory concerns were also associated with tau
aggregation in posterior brain regions, including the parietal
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pants were included, the self-based memory concerns were
significantly associated with tau aggregation in bilateral
frontal lobes and the right temporal lobe, while the informant
memory concerns were also correlated with tau burden in the
left parietal lobe and bilateral occipital lobes.
Our data suggest that self-based memory concerns corre-
late more strongly with tau aggregation in regions typical of
conscious internal thought processes (i.e., frontal lobe, spe-
cifically themedial prefrontal region), while informantmem-
ory concerns correlate more strongly with tau aggregation in
posterior regions typical of more progressed MCI and AD
patients. These posterior regions may be involved with the
more outward signs of cognitive decline that can be noticed
by an observer who knows the individual well. In support of
this implication of our results, the voxelwise analysis re-
vealed that only self-basedmemory concerns were correlated
with tau aggregation in the bilateral anterior cingulate, while
only informant memory concerns were correlated with tau
aggregation in the supramarginal gyri. The anterior cingulate
has been shown to be involved in decision-making [32],
while the supramarginal gyrus is involved in language
perception and processing [33]. While correlations within
these specific brain regions are interesting, future research
focused on the relationship between subjective memory con-
cerns and regional pathology will be necessary to confirm the
relationships that we observe here.
Because both self-based cognitive complaints and patho-
logical changes in the frontal lobe have been shown to be
correlated with depression [7,10,11,34], we used GDS
scores as a covariate along with age, sex, and years of
education to ensure that depressive symptomology was not
a confound in the observed correlations. The inclusion of
this score as a covariate did not significantly change the
patterns of association; the self-based memory concerns
were still significantly correlated to tau in the frontal region
(data not shown). Individuals’ depressive symptoms have
been shown to increase informant-based cognitive complaints
in other studies as well [15,35], but the pattern of association
between informant based memory concerns and tau was not
changed when GDS scores were used as a covariate (data
not shown). It is still possible that some of the participants
experienced subtle depressive symptoms that were not
reflected in the GDS scores but still influenced their
perceptions of their own cognitive functioning. Future
studies exploring the interactions between depression,
cognitive concerns, and AD pathophysiology are warranted.
Overall, our findings suggest that subjectivememory con-
cerns have the potential to be optimized and used as part of a
screening protocol for AD-related pathology and disease
progression in adults with preclinical or prodromal stages
of AD. Along with the differing regions of tau association
between the two measures of subjective memory concern,
this finding suggests that using both self- and informant mea-
sures together may provide important complementary infor-
mation, such that high scores on both measures may suggesta greater overall tau burden in the brain. Finally, these results
provide a potential biological explanation for the previous
finding that using self– and informant memory concerns
together is a better predictor of future progression to MCI
or AD than either measure alone [5].
This study does have some potential limitations. First, our
sample size, especially in the amyloid-positive subanalysis,
was relatively small, which could lead to bias. Although we
included all available CN, SMC, and EMCI participants in
ADNI-2 who had tau scans at the time of our analyses, we
recognize that the CN group had more APOE ε4 carriers
than expected in the general population and that the amyloid
positivity surprisingly did not differ between the diagnostic
groups. Second, we also acknowledge that there may have
been unforeseen selection bias in the ADNI-2 study. Future
studies in larger samples will help to support the present
findings. In addition, the SMC group from ADNI-2 was
defined on the basis of subjective- or self-based memory
complaints but not informant-based concerns. Therefore,
there was not a group in this study for participants who
had solely informant-based complaints in the context of
normal or above average cognitive functioning. Third, this
study only evaluated cross-sectional data; future studies
with longitudinal data are needed to address changes in
self- and informant concerns across the disease spectrum
and their association with changes in AD pathophysiology.
Evaluating whether CN individuals who later progress to
AD show different patterns of self– and/or informant cogni-
tive concerns and differing patterns of association of these
concerns with AD pathology could further validate quantita-
tive assessment of memory concerns as a useful screening
tool. Finally, we used Talairach Daemon to define the brain
regions from our voxelwise analysis. Although this atlas is
not specific to our study or to an aging population, we felt
that it was the most appropriate tool to use in this case. A
standardized atlas specific for older adults has not been
defined in the literature, and our small sample size kept us
from producing our own study-specific atlas. We do not
expect that extensive atrophy should confound the results
of the Talairach Daemon atlas in our preclinical AD popula-
tion, and we visually inspected labeled regions for accuracy.
However, we acknowledge that use of this nonspecific atlas
may have caused minor labeling issues in our aging partici-
pants.
In summary, we demonstrated that both self– and infor-
mant memory concerns are associated with tau aggregation
in adults at risk for AD. Furthermore, we found that self– and
informant memory concerns correlate with tau aggregation
in spatially different patterns of association throughout the
brain. Overall, these findings suggest that both self– and
informant memory concerns have the potential to be used
as part of a screening process for preclinical AD and that
they may also provide complementary information about
both future conversion and AD-related pathological pat-
terns. Although future studies are needed, it may be the
case that the discrepancy between self– and informant
C.G. Swinford et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 10 (2018) 322-331330memory concerns could help determine the location of tau
aggregation for individuals, thus adding information for bet-
ter detection, diagnosis, and prognosis of future decline.
Future studies with larger sample sizes and longitudinal
data will help to further elucidate which measures of
perceived cognitive decline and which patterns of tau aggre-
gation are most accurate at predicting progression to AD.Acknowledgments
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1. Systematic review: To review what is already known
about relationships between self– and informant
cognitive concerns and Alzheimer’s disease (AD)
biomarkers, we searched PubMed for: “cognitive
complaints (CC),” “neuroimaging,” and “Alz-
heimer’s disease (AD).” We then summarized the
findings from the resulting articles into a brief over-
view of the relationships between self– and infor-
mant cognitive concerns and AD biomarkers.
2. Interpretation: Our results suggest that both self– and
informant memory concerns have the potential to be
used as part of a screening process for preclinical AD
and that self- and informant concerns will likely pro-
vide complementary information about AD-related
pathological patterns and future conversion.
3. Future directions: Studies with larger sample sizes
and longitudinal data will help to further elucidate
the self- and informant concerns and tau aggregation
patterns that most accurately predict progression to
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